BRIEF published on 11/13/2025 at 07:35, 2 months 29 days ago Dermapharm maintient sa stabilité malgré les ajustements de son portefeuille Croissance Et Bénéfices Dermapharm Restructuration Du Portefeuille Résultats Financiers De 2025 Médicaments De Marque
BRIEF published on 11/13/2025 at 07:35, 2 months 29 days ago Dermapharm Maintains Stability Amid Portfolio Adjustments Growth And Earnings Branded Pharmaceuticals Dermapharm 2025 Financial Results Portfolio Restructuring
PRESS RELEASE published on 11/13/2025 at 07:30, 2 months 29 days ago Stable earnings despite portfolio adjustment - 2025 guidance confirmed, strong growth in branded pharmaceuticals Dermapharm Holding SE reports stable earnings despite portfolio adjustments in Q3 2025, confirms 2025 guidance and strong growth in branded pharmaceuticals Pharmaceuticals Growth Earnings Dermapharm Holding SE Portfolio Adjustment
BRIEF published on 08/26/2025 at 07:35, 5 months 17 days ago Dermapharm annonce une activité stable au premier semestre 2025 et une croissance de l'EBITDA au deuxième trimestre Résultats Financiers Croissance De L'EBITDA Stabilité Des Revenus Produits Pharmaceutiques De Marque Performances De Dermapharm
BRIEF published on 08/26/2025 at 07:35, 5 months 17 days ago Dermapharm Reports Stable Business in H1 2025 and Q2 EBITDA Growth Financial Results EBITDA Growth Revenue Stability Branded Pharmaceuticals Dermapharm Performance
PRESS RELEASE published on 08/26/2025 at 07:30, 5 months 17 days ago Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter Dermapharm confirms stable business development in H1 2025 with EBITDA growth in Q2. Full-year guidance for 2025 reiterated. Branded pharmaceuticals main growth driver Revenue Pharmaceuticals EBITDA Growth Dermapharm H1 2025
BRIEF published on 08/12/2025 at 07:35, 6 months ago Dermapharm Holding SE poursuit sa croissance au deuxième trimestre 2025 Prévisions De Revenus Croissance De L'EBITDA Produits Pharmaceutiques De Marque Dermapharm Performances Du Deuxième Trimestre 2025
BRIEF published on 08/12/2025 at 07:35, 6 months ago Dermapharm Holding SE Continues Growth in Q2 2025 Revenue Forecast EBITDA Growth Branded Pharmaceuticals Dermapharm Q2 2025 Performance
PRESS RELEASE published on 08/12/2025 at 07:30, 6 months ago Dermapharm Holding SE remains on projected growth trajectory in Q2 2025 Dermapharm Holding SE reports Q2 2025 results in line with expectations. Confirms full-year guidance of EUR 1,160–1,200 million revenue and EUR 322–332 million EBITDA Pharmaceuticals EBITDA Growth Dermapharm Holding SE Full-year Guidance Q2 2025 Results
BRIEF published on 06/26/2025 at 17:48, 7 months 16 days ago Dermapharm Holding SE Approves EUR 0.90 Dividend Per Share Sustainability Dividend AGM Financial Outlook Dermapharm
Published on 02/12/2026 at 19:18, 1 hour 22 minutes ago Verdera Energy Closes $20 Million Financing and Provides Update to Proposed Qualifying Transaction and Listing on the TSX-V
Published on 02/12/2026 at 19:00, 1 hour 40 minutes ago Nepra Foods Announces USD$487,849 Debt Conversion
Published on 02/12/2026 at 17:00, 3 hours 40 minutes ago Diamcor Provides Update on Discharge of Security and Indebtedness, and Granting of Extension of Time to Hold the 2025 Annual General Meeting
Published on 02/12/2026 at 15:00, 5 hours 40 minutes ago Onco-Innovations Announces Amendment to Private Placement Pricing
Published on 02/12/2026 at 14:30, 6 hours 10 minutes ago MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Published on 02/12/2026 at 20:05, 35 minutes ago CGTN AMERICA & CCTV UN: CMG Presents "Prelude to the Spring Festival Gala" in New York City, Celebrating the Year of the Horse
Published on 02/12/2026 at 19:30, 1 hour 10 minutes ago SAUDI ARABIA ANNOUNCES 2026 FUTURE AVIATION FORUM TO CONVENE GLOBAL AVIATION LEADERS, EXTENDS RECORD-BREAKING AVIATION GROWTH
Published on 02/12/2026 at 19:10, 1 hour 30 minutes ago iGarden and French National Swimming Association Announce Exclusive Strategic Partnership and Reveal French Market Roadmap
Published on 02/12/2026 at 17:45, 2 hours 55 minutes ago ENOGIA: Chiffre d’affaires de l’exercice 2025 : +57% (12,6 M€)
Published on 02/12/2026 at 17:45, 2 hours 55 minutes ago MR.BRICOLAGE SA: ENTERING INTO A NEW SYNDICATED CREDIT FACILITY
Published on 02/12/2026 at 17:45, 2 hours 55 minutes ago Mr.Bricolage : Mise en place d'un nouveau contrat de crédit
Published on 02/12/2026 at 17:45, 2 hours 55 minutes ago Chiffre d’affaires des 9 premiers mois de l’exercice 2025/2026
